Oyster Mushroom (Pleurotus ostreatus)
One of the most popular edible mushrooms in Poland, containing a natural compound structurally similar to lovastatin — studied mainly for its effects on lipid profile and immunity.
Number of studies
2
Safety
Moderate
Time to effects
Effects on lipid parameters were observed after 21 days of regular intake in the clinical study.
Monthly cost
Jako żywność: ok. 20-40 zł przy 2-3 porcjach tygodniowo; jako ekstrakt: 40-80 zł
Price in Poland
Świeży boczniak: 10-18 zł/kg; ekstrakt w kapsułkach: 40-70 zł za 60 kapsułek
Who it's for
Boczniak ostrygowaty jest jednym z najtańszych i najłatwiej dostępnych grzybów w Polsce.
Indicative prices for the Polish market — we don't point to specific retailers; the real price depends on the manufacturer, form and place of purchase.
Table of contents
TL;DR
One of the most popular edible mushrooms in Poland, containing a natural compound structurally similar to lovastatin — studied mainly for its effects on lipid profile and immunity.
- →Moderate reduction of triglycerides and oxidized LDL with regular intake (human studies)
- →A trend toward lower total cholesterol in intervention studies
- →A source of beta-glucans supporting immune cell activity
| Latin name | Pleurotus ostreatus |
|---|---|
| Family | Pleurotaceae |
| Active compounds | Mevinolin (lovastatin), beta-1,3/1,6-D-glucans, ergothioneine, plant sterols |
| Form | Fresh/dried mushrooms, capsule extract (standardized for beta-glucans) |
| Research level | Moderate — two intervention studies in humans |
| Interactions | Theoretical additive effect with statin drugs |
| Status | Functional food; extracts are also available as dietary supplements |
Understand
Overview
The oyster mushroom (Pleurotus ostreatus), alongside the button mushroom, is one of the most widely cultivated and purchased edible mushrooms in Poland — available year-round, at a price comparable to vegetables. For decades it has been used in the kitchen as a low-calorie, meaty ingredient in vegan dishes.
The oyster mushroom is one of the best-studied functional mushrooms in terms of its effect on lipid metabolism. Its fruiting bodies contain a compound structurally related to lovastatin, as well as beta-glucans and ergothioneine.
The oyster mushroom can genuinely help people with mildly elevated triglycerides or oxidized LDL who want to support their lipid profile through diet — this is the only area confirmed by independent intervention studies in humans. It won't help people with significantly elevated cholesterol who need a substantial LDL reduction — the mevinolin content in fruiting bodies is too low and unstable to work like a statin drug. For people already taking statins, the oyster mushroom can be a safe dietary addition, but given the theoretical additive effect, it's worth discussing with a doctor.
Where it's found
It grows naturally on dying and dead hardwood trees (including beech, oak, poplar) in the temperate climates of Europe, Asia, and North America. It's easy to cultivate on straw and sawdust, making it one of the cheapest cultivated mushrooms — including in Poland.
History of use
Cultivated for food for more than a hundred years — first on a commercial scale in Germany during World War I, as a food substitute during shortages.
Mechanism of action
The fruiting bodies contain mevinolin (lovastatin) — a competitive inhibitor of HMG-CoA reductase, at a much lower concentration than in pharmaceutical preparations. At the same time, the mushroom supplies beta-1,3/1,6-D-glucans that modulate immune system activity, plus fiber and plant sterols that limit cholesterol absorption.
HMG-CoA reductase, blocked by mevinolin, is the rate-limiting enzyme of the mevalonate pathway — the main route of cholesterol synthesis in the liver. Beta-1,3/1,6-D-glucans bind to receptors on immune cells, such as dectin-1, modulating their activity. Ergothioneine is actively transported into tissues via the OCTN1 transporter and accumulates especially in sites exposed to oxidative stress, acting as an intracellular antioxidant with a relatively long half-life.
Inhibition of HMG-CoA reductase
Mevinolin competitively inhibits the key enzyme of the mevalonate pathway, slowing cholesterol synthesis in the liver.
Binding of sterols and fiber
Plant sterols and fiber limit cholesterol absorption from the digestive tract.
Activation of beta-glucan receptors
Beta-1,3/1,6-D-glucans bind to receptors on immune cells (e.g., dectin-1), modulating their activity.
Antioxidant action of ergothioneine
Ergothioneine accumulates in tissues exposed to oxidative stress via the OCTN1 transporter.
Clinical effect
The combined action of these mechanisms translates, in intervention studies, into lower triglycerides and oxidized LDL.
Evidence: moderate — based on 2 studies in this database.
Benefits
Common myths
MythEating oyster mushrooms works like taking a prescription statin.
FactThe content of the lovastatin-like compound is very low and unstable — the effect likely results instead from the combined action of fiber, beta-glucans, and plant sterols.
Forms & variants
Oyster Mushroom (Pleurotus ostreatus) comes in several forms that differ in bioavailability and use case — the form you pick genuinely matters for how effective the supplementation is.
Fresh oyster mushroom
The most common form — available year-round.
Best for: Daily, natural addition to the diet
Extract capsules (standardized for beta-glucans)
A concentrated supplement.
Best for: People looking for convenient, concentrated supplementation
Practice
Frequently asked questions
No. The effect is much weaker and less predictable than that of statin drugs — it can be a valuable dietary addition, not a substitute for pharmacotherapy.
Dosage & timing
Typical dose
As food: 100–200 g of fresh mushrooms several times a week. In the clinical study: a soup made with 30 g of dried mushroom daily for 21 days
Form
Fresh or dried mushrooms; extracts standardized for beta-glucans are usually available in doses of 500–1,000 mg
This information is educational and does not replace consultation with a doctor or dietitian.
Best times to take it
- As a meal ingredient
What to combine with
Good combinations
King Oyster Mushroom (Pleurotus eryngii) — A natural pairing within the same genus
Shiitake — A common combination in cooking and functional mushroom supplementation
Safety
Side effects & contraindications
Possible side effects
Generally very well tolerated as food
Occasionally: gastrointestinal discomfort with large portions
Contraindications
Mushroom allergy
Always eat well cooked
Interactions
Theoretical additive effect with cholesterol-lowering drugs (statins)
Is it worth taking?
Who it's for
- People wanting to naturally support their lipid profile as part of a balanced diet
- People looking for a low-calorie, plant-based source of fiber and protein to replace meat
Not for
- Mushroom allergy
- Always eat well cooked
Evidence
Worth knowing
One of the most widely cultivated edible mushrooms in Poland, alongside the button mushroom.
Contains a natural compound structurally related to lovastatin.
Studies
Daily consumption of a soup made with 30 g of dried oyster mushroom for 21 days significantly lowered triglyceride and oxidized LDL levels in healthy adults.
Schneider I et al., Journal of Functional Foods, 2011
Lipid lowering effects of oyster mushroom (Pleurotus ostreatus) in humans
Moderate evidenceSchneider I, Kressel G, Meyer A, Krings U, Berger RG, Hahn A · Journal of Functional Foods · 2011
A 21-day study in 20 healthy adults: daily consumption of a soup made with 30 g of dried oyster mushroom significantly lowered triglycerides and oxidized LDL.
View studyAntihyperlipidemic effects of Pleurotus ostreatus in HIV-infected individuals taking antiretroviral therapy
Moderate evidenceAbrams DI, et al. · BMC Complementary and Alternative Medicine · 2011
An 8-week study with supplementation of 15 g of freeze-dried oyster mushroom daily showed a significant drop in triglycerides.
View studySources & bibliography
Citations are illustrative for this demo version and require full bibliographic verification by the editorial team before production publication.
Compare with similar entries
About the authors of this entry
Author
Michał NowakClinical Dietitian
Michał specializes in metabolic nutrition, intermittent fasting and sports supplementation.
61 publications on this site
Medical review
dr Piotr ZielińskiEndocrinologist
Piotr reviews content on hormones, metabolic health and supplement pharmacology.
131 publications on this site
Related entries
4.1King Oyster Mushroom (Pleurotus eryngii)
The largest species in the oyster mushroom genus, prized in the kitchen for its meaty stem — studied in early research, mostly in animal models, for effects on lipid metabolism and blood sugar.
4.3Shiitake
A culinary-functional mushroom rich in lentinan and beta-glucans, studied clinically for immune modulation and lipid profile — one of the best-researched functional mushrooms on the market.
4.4Lion's Mane
A functional mushroom studied for its effect on nerve growth factor (NGF) and cognitive function — human evidence is still preliminary.
4.5Turkey Tail
The mushroom behind PSK and PSP — the only fungal polysaccharides registered in Japan as drugs supporting chemotherapy. Among the most solid clinical evidence of any functional mushroom, but this is NOT a standalone cancer therapy.
4.2Reishi (Ganoderma lucidum)
A functional mushroom with more than 2,000 years of history in Chinese and Japanese medicine, studied for its immune-modulating effects — human clinical evidence, however, remains modest and partly contradictory.
4.1Almond Mushroom (Agaricus blazei)
A mushroom from the Brazilian forests studied mainly for immune modulation and blood-sugar support — human evidence is mixed and preliminary, despite the supplement's considerable popularity.
4.1Maitake (Hen of the Woods)
A functional mushroom also known as 'Hen of the Woods,' studied mainly for immune modulation (D-fraction) in oncology and, more preliminarily, for carbohydrate metabolism — evidence in healthy people remains limited.
4.1Mesima (Phellinus linteus)
A tree-growing mushroom from Korea and Japan, sold commercially as Mesima — one of the few functional mushrooms with real, randomized clinical trials in humans assessing effects on immunity, not just in-vitro data.
Related articles
Opinie ekspertówFunctional Mushroom Ranking: Which Ones Have the Strongest Scientific Evidence
Reishi, shiitake, lion's mane, cordyceps, chaga... The VitMode knowledge base covers more than 50 species of medicinal mushrooms. We picked the five with the most solid evidence base and ranked them by specific use case.
August 18, 2026
PoradnikiCold Showers and Immunity: Do You Really Get Sick Less?
"Cold exposure boosts your immune system" is one of the most repeated claims in biohacking — but the newest, largest meta-analysis on the topic shows something more complex: inflammation rises short-term, and immune markers don't budge. There is, though, one real, if surprising, long-term effect. We break down the evidence.
August 22, 2026
PoradnikiZinc and the Common Cold: Does It Really Shorten It?
"Zinc shortens colds" is one of the oldest claims in supplementation — and one of the few backed by meta-analyses with concrete numbers. But this story has an instructive plot twist: part of the key Cochrane evidence was withdrawn over data errors. We break down the topic, including what you shouldn't trust uncritically.
August 22, 2026
PoradnikiMuscle Pain from Statins: Drug Effect or Nocebo?
Millions of patients stop taking statins because of muscle pain that, according to the first trial ever designed to settle the question, has nothing to do with the drug's pharmacology in 90% of cases. In the SAMSON experiment, participants reported nearly identical pain severity while taking the statin and while taking a placebo. That doesn't mean the pain is 'imaginary' — it means the pill itself, not its active ingredient, is usually not the source.
August 23, 2026
Comments (2)
- KW
Kasia W. 2 weeks ago
Very clearly explained, especially the interactions section — I hadn't seen it laid out this well anywhere else.
- MT
Marek T. a month ago
Are you planning to update this with the newest study from this year? I saw an interesting meta-analysis.